Clinical Trial: A Study of Deucravacitinib to Treat LPP and FFA

Study Status: RECRUITING
Recruit Status: RECRUITING
Study Type: INTERVENTIONAL




Official Title: Deucravacitinib (BMS-986165) in the Treatment of Lichen Planopilaris

Brief Summary: The purpose of this clinical research study is to learn more about the use of Deucravacitinib in the treatment of Lichen Planopilaris.